Part of Weill Cornell Graduate School of Medical Sciences. A convergence of Weill Cornell Medical College and the Sloan-Kettering Institute, we are a premiere school in biomedical research. Read more about our programs of study:
The research activities of the Cornell Pharmacology Program faculty cover broad areas of modern pharmacological sciences. Faculty carry out research in cancer pharmacology, neuropharmacology, cardiovascular pharmacology, drug metabolism, toxicology, proteomics, molecular pharmacology, receptors and signal transduction, and drug design.
POSTDOCTORAL RESEARCH:
PHOTOGRAPHS:
Text size:
Dr. Charles Inturrisi's 2002 paper entitled "Clinical pharmacology of opioids for pain" was one of the ten most frequently cited articles ( #4) from 2001-2009 in the Clinical Journal of Pain
Ms. Noel Chan, a Pharmacology PhD Student in Dr. Levi's laboratory, is one of the authors on the recently published paper titled "Aldehyde Dehydrogenase Activation Prevents Reperfusion Arrhythmias by Inhibiting Local Renin Release From Cardiac Mast Cells", published in Circulation 2010;122:771-781.
Dr. Marcus M. Reidenberg was one of the authors of the International Union of Basic and Clinical Pharmacology (IUPHAR) brochure, Clinical Pharmacology in Research, Teaching, and Health Care, published in Basic and Clinical Pharmacology and Toxicology 2010; 107: 531-559. It was presented to IUPHAR at WorldPharma 2010 on July 20. He was then a member of a small group of IUPHAR clinical pharmacologists who met with World Health Organization representatives to develop the process by which the WHO will accept and publish this brochure as an official WHO document.
Tuesday, September 21, 2010 Room A-250, 4:00 PM
Federico Corti, PhD, Postdoctoral Fellow, Dr. Levi's laboratory
"The ectonucleotidase CD39 modulates transmitter release from sympathetic neurons"
Ji-eun Oh, PhD, Instructor, Dr. Toth's laboratory
"CpG methylation signature in a mouse model of anxiety"
